Trial site
Shengli Oilfield Central Hospital
- 9running trials
- 5closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Stroke5 trials
- Atrial fibrillation2 trials
- Gastric and oesophageal cancer2 trials
- Hepatitis B1 trial
- Liver and biliary tract cancer1 trial
- Migraine1 trial
- Obstructive sleep apnoea1 trial
- Osteoporosis1 trial
- Psoriasis1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Status
- Completed5 trials
- Recruiting5 trials
- Not yet recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Capital Medical University3 trials
- Beijing Anzhen Hospital2 trials
- Peking Union Medical College Hospital2 trials
- Qilu Hospital of Shandong University2 trials
- Newsoara Biopharma Co., Ltd.1 trial
- and 4 more
Running trials
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
Recruiting
Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation
Not yet recruiting
Recruiting
Recruiting
Recruiting
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
Active, not recruiting
Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis
Recruiting
Recruiting
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer2 recruiting
- Stroke2 recruiting
- Atrial fibrillation1 recruiting
- Hepatitis B1 recruiting
- Liver and biliary tract cancer1 recruiting
- Obstructive sleep apnoea1 recruiting
- Osteoporosis1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Completed
Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)
Completed
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
Completed
HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.
Completed
rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026